Synergy Pharmaceuticals to Present at Aegis Capital 2013 Healthcare Conference
Synergy Pharmaceuticals to Present at Aegis Capital 2013 Healthcare Conference
NEW YORK--(BUSINESS WIRE)-- Synergy Pharmaceuticals, Inc. (NAS: SGYP) , a developer of new drugs to treat gastrointestinal diseases and disorders, today announced that its President and CEO, Gary S. Jacob, Ph.D., will present at the Aegis Capital 2013 Healthcare Conference being held at The Encore at Wynn Las Vegas, September 25-28. The presentation is scheduled for Saturday, September 28th at 10:30 a.m. (PDT).
About Synergy Pharmaceuticals Inc.
Synergy Pharmaceuticals is a biopharmaceutical company focused on the development of new drugs to treat patients with gastrointestinal (GI) diseases and disorders. Synergy's lead proprietary drug candidate, plecanatide, is a synthetic analog of the human GI hormone, uroguanylin, and functions by activating the guanylate cyclase-C (GC-C) receptor on epithelial cells of the GI tract. In early 2013, Synergy announced positive results from a large multicenter trial of plecanatide in patients with chronic idiopathic constipation (CIC) and recently completed an end-of-phase 2 meeting with the U.S. Food and Drug Administration (FDA) covering the registration program for plecanatide to treat CIC. Synergy is also developing plecanatide for the treatment of irritable bowel syndrome with constipation (IBS-C), recently announcing that it had reached the halfway mark for total enrollment in a plecanatide phase 2b clinical trial in patients with IBS-C. Synergy's second GC-C agonist, SP-333, is in clinical development to treat inflammatory bowel disease and other GI conditions and has recently completed its first phase I trial in healthy volunteers. More information is available at www.synergypharma.com .
Synergy Pharmaceuticals
Media Contact
Gem Gokmen
Office: 212-584-7610
Mobile: 646-637-3208
ggokmen@synergypharma.com
or
Investor Contact
Bernard Denoyer
Office: 212-297-0020
Mobile: 203-300-8147
bdenoyer@synergypharma.com
KEYWORDS: United States North America Nevada New York
INDUSTRY KEYWORDS:
The article Synergy Pharmaceuticals to Present at Aegis Capital 2013 Healthcare Conference originally appeared on Fool.com.
Try any of our Foolish newsletter services free for 30 days. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy.
Copyright © 1995 - 2013 The Motley Fool, LLC. All rights reserved. The Motley Fool has a disclosure policy.
